ArticleMedical research archives2026
Arsenic Exposure During Pregnancy: Impacts to Maternal and Offspring Cardiovascular Health.
Article in Medical research archives, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Cardiovascular disease (CVD) is the leading cause of pregnancy-related deaths, with rates continuing to rise. While older maternal age and preexisting conditions such as obesity, diabetes and hypertension contribute to this trend, they do not fully account for it, suggesting a critical role for environmental factors. A major environmental concern is inorganic arsenic (iAs), which contaminates the food and water supply of over 140 million people worldwide. Exposure to iAs has been linked to a number of chronic diseases including cancer, neurodegenerative disorders and heart disease. During pregnancy, gestational iAs exposure poses a substantial threat to maternal and fetal health. It is linked with a higher risk of maternal hypertension, preeclampsia, and structural heart changes during and after pregnancy. Concurrently, it drives fetal complications including pre-term delivery, congenital heart defects and low birth weight. Furthermore, these early-life exposures predispose offspring to lifelong CVD. Herein, we summarize current evidence regarding the adverse impacts of prenatal iAs exposure on the cardiovascular health of mothers and their offspring. We underscore the need to elucidate the underlying biological mechanisms to inform targeted preventive strategies, therapeutics, and public health policies aimed at combating the rising global maternal mortality.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.